• The patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 2030

    Roots Analysis is pleased to announce the publication of its recent study, titled, “Patient Recruitment and Retention Services Marker, 2019-2030.”

    The report offers a comprehensive study of the current scenario and future potential of the players providing patient enrollment and retention services. The study features an in-depth analysis, highlighting the capabilities of the various stakeholders in this domain. In addition to other elements, the study includes:
     A detailed assessment of the current market landscape of companies offering patient recruitment and retention services.
     An analysis of the most active regions (in terms of patient recruitment activity) engaged in this domain, featuring schematic world map representations that highlight key hubs across the globe.
     An insightful 2X2 representation of the results of a competitiveness analysis of various service providers highlighting capable players in this domain, based on their respective capabilities.
     Comprehensive profiles of patient recruitment and retention service providers (shortlisted on the basis of the number of services).
     An analysis of the partnerships that have been established in this domain, in the recent past
     A review of emerging trends in the industry to overcome the challenges associated with patient recruitment and retention
     A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
     Therapeutic Area
     Oncology
     Infectious Diseases
     Cardiovascular Diseases
     CNS Disorders
     Respiratory Disorders
     Metabolic Disorders
     Others

     Steps in Patient Recruitment Process
     Pre-screening
     Screening

     Phase of Development
     Phase I
     Phase II
     Phase III
     Phase IV

     Key Geographical Region
     North America
     Europe
     Asia-Pacific
     Rest of the world

    To request a sample copy / brochure of this report, please visit this
    https://www.rootsanalysis.com/reports/245/request-sample.html

    Transcripts of interviews held with the following senior level representatives of stakeholder companies
     Simon Klaasen, Co-founder and Managing Director, Link2Trials
     Hagit Nof, Chief Operation Officer and Business Development Officer, nRollmed
     Paul Ivsin, Managing Director, Seeker Health

    Key companies covered in the report
     Acurian
     BBK Worldwide
     Bright Pharmaceuticals Services
     ClinEdge
     CSSi
     CTM
     FIDELIS RESEARCH
     Ignite Data
     Integrated Clinical Trial Services
     MMG
     Pacific Groove
     Polaris BioPharma Consulting
     Topstone Research
     TrialWire
     Tudor Reilly Health
     WCCT Global

    For more information please click on the following link:
    https://www.rootsanalysis.com/reports/view_document/patient-recruitment-and-retention-services-market-2019-2030/245.html

    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

    Contact Information
    Roots Analysis Private Limited
    Ben Johnson
    +1 (415) 800 3415
    +44 (122) 391 1091
    Ben.johnson@rootsanalysis.com
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis
    Medium - https://medium.com/@RootsAnalysis
    Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/
    Quora - https://rootsanalysisinsights.quora.com/
    The patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 2030 Roots Analysis is pleased to announce the publication of its recent study, titled, “Patient Recruitment and Retention Services Marker, 2019-2030.” The report offers a comprehensive study of the current scenario and future potential of the players providing patient enrollment and retention services. The study features an in-depth analysis, highlighting the capabilities of the various stakeholders in this domain. In addition to other elements, the study includes:  A detailed assessment of the current market landscape of companies offering patient recruitment and retention services.  An analysis of the most active regions (in terms of patient recruitment activity) engaged in this domain, featuring schematic world map representations that highlight key hubs across the globe.  An insightful 2X2 representation of the results of a competitiveness analysis of various service providers highlighting capable players in this domain, based on their respective capabilities.  Comprehensive profiles of patient recruitment and retention service providers (shortlisted on the basis of the number of services).  An analysis of the partnerships that have been established in this domain, in the recent past  A review of emerging trends in the industry to overcome the challenges associated with patient recruitment and retention  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Therapeutic Area  Oncology  Infectious Diseases  Cardiovascular Diseases  CNS Disorders  Respiratory Disorders  Metabolic Disorders  Others  Steps in Patient Recruitment Process  Pre-screening  Screening  Phase of Development  Phase I  Phase II  Phase III  Phase IV  Key Geographical Region  North America  Europe  Asia-Pacific  Rest of the world To request a sample copy / brochure of this report, please visit this https://www.rootsanalysis.com/reports/245/request-sample.html Transcripts of interviews held with the following senior level representatives of stakeholder companies  Simon Klaasen, Co-founder and Managing Director, Link2Trials  Hagit Nof, Chief Operation Officer and Business Development Officer, nRollmed  Paul Ivsin, Managing Director, Seeker Health Key companies covered in the report  Acurian  BBK Worldwide  Bright Pharmaceuticals Services  ClinEdge  CSSi  CTM  FIDELIS RESEARCH  Ignite Data  Integrated Clinical Trial Services  MMG  Pacific Groove  Polaris BioPharma Consulting  Topstone Research  TrialWire  Tudor Reilly Health  WCCT Global For more information please click on the following link: https://www.rootsanalysis.com/reports/view_document/patient-recruitment-and-retention-services-market-2019-2030/245.html About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact Information Roots Analysis Private Limited Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/
    Request Sample - Patient Recruitment and Retention Services Market (2nd Edition) 2021-2030 | Industry Analysis | Market Size | 2030
    Given the active involement of close to 140 players, the patient recruitment services market is anticipated to grow at an annualized rate of ~4% till 2030...
    WWW.ROOTSANALYSIS.COM
    0 Comments 0 Shares
  • The site management organizations (SMO) market

    The rapidly growing clinical pipeline and challenges associated with the conduct of clinical trials in a cost and time effective manner, has presented lucrative opportunities for service providers with expertise in clinical trial site management

    The Site Management Organizations Market report features an extensive study of the current market landscape and future potential of the site management organizations market.

    Roots Analysis has announced the addition of “Site Management Organizations (SMO) Market, 2021 – 2035” report to its list of offerings

    In recent years, drug / device developers have demonstrated a preference to continue relying on SMOs for conducting clinical trials in order to significantly optimize trial cost and research timelines. Driven by the steady growth in clinical research activity and inherent benefits offered by SMOs, the market opportunity for such players is projected to grow at a significant pace in the foreseen future.

    To order this 270+ page report, which features 95+ figures and 120+ tables, please visit
    https://www.rootsanalysis.com/reports/site-management-organizations-market.html

    Key Market Insights

    Around 250 companies across the world claim to offer clinical trial site management services
    Majority (43%) of the industry stakeholders are headquartered in North America, followed by those based in Asia-Pacific (32%) and Europe (19%). In addition, 25% of the companies engaged in this domain offer site management services across the globe, followed by those providing services in Asia-Pacific (23%).

    200+ partnerships were established in this domain, during the period 2016-2021
    Service alliances (26%) and clinical trial agreements (23%) emerged as the most common types of partnership models adopted by stakeholders engaged in this domain. Nearly 65% of the deals in this domain were established after 2018, with the maximum activity being reported in 2021 (56).

    ~USD 1 billion invested in various domain focused initiatives, since 2015
    Maximum number of funding instances (21%) were reported in 2021, amounting to USD 614 million in capital investments. A significant number of funding instances (43%) were venture capital rounds, followed by instances of other equity (29%) and grants (7%).

    Till 2035, annual demand for clinical trial study participants is expected grow at a CAGR of 8.2%
    Currently, North America and Asia-Pacific hold the majority share of the overall demand for clinical trial study participants (60%). By 2035, the demand for patients in clinical trial studies is projected to reach 25 million. Further, currently, the highest demand is generated via phase III trials (43%), followed by phase IV studies (38%).

    North America and Europe are anticipated to capture close to 65% of the market share, by 2035
    In addition, the market in Asia-Pacific is likely to grow at a relatively faster pace (9%) in the long term. Further, in 2035, the majority share (~45%) of clinical trial site management revenues is likely to be generated from trials focused on phase III evaluation of clinical studies.

    To request a sample copy / brochure of this report, please visit
    https://www.rootsanalysis.com/reports/site-management-organizations-market.html

    Key Questions Answered
     Who are the leading players engaged in the clinical trial site management domain?
     What is the relative competitiveness of different site management organizations?
     What type of partnership models are commonly adopted by stakeholders in this industry?
     What is the capital investments trend in the site management organizations domain?
     Which are the most active clinical trial centers?
     What are the major market trends and driving factors that are likely to impact the growth of site management organizations market?
     How is the current and future market opportunity likely to be distributed across key market segments?

    The financial opportunity within the SMOs market has been analyzed across the following segments:

     Therapeutic Areas
     Oncological Disorders
     CNS Disorders
     Infectious Diseases
     Respiratory Disorders
     Cardiovascular Diseases
     Endocrine Disorders
     Gastrointestinal Disorders
     Musculoskeletal Diseases
     Immunological Disorders
     Others

     Trial Phases
     Phase I
     Phase II
     Phase III
     Phase IV

     Clinical Trial Components
     Site Management
     Onsite Monitoring
     Project Management
     Data Management
     Regulatory Affairs
     Logistics
     Quality Control
     Others

     Types of Interventions
     Therapeutics
     Devices
     Surgical Procedure

     Key Geographical Regions
     North America
     Europe
     Asia-Pacific
     Latin America
     MENA
     Rest of the World

    The report also features inputs from eminent industry stakeholders, according to whom, complexities associated with clinical trial processes and increasing clinical pipeline will drive the growth of the third-party service providers, such as SMOs, engaged in this domain, in the coming future. The report includes detailed transcripts of discussions held with the following experts:
     Vinod Gyanchandani (Country Head - Clinical Operations, GDD Experts)
     Marisa Vico (Medical Director and Operations Manager, SMO – Dra. Marisa Vico)
     Eugene Winifred (Project Manager, Syncretic Clinical Research Services)

    The research includes profiles of key players (listed below); each profile features a brief overview of the company, details related to its site management service portfolio, recent developments and an informed future outlook.
     FOMAT Medical Research
     Parexel
     Pharm-Olam
     Veristat
     WCCT Global
     Worldwide Clinical Trials
     CROMSOURCE
     Fidelis Research
     Scandinavian CRO
     TFS HealthScience
     Trialbee
     CMIC
     George Clinical
     Tigermed
     Veeda Clinical Research

    For additional details, please visit
    https://www.rootsanalysis.com/reports/site-management-organizations-market.html
    or email sales@rootsanalysis.com

    You may also be interested in the following titles:
    1. Patient Recruitment and Retention Services Market (2nd Edition): Industry Trends and Global Forecasts, 2021-2030
    2. Pharmaceutical Contract Research Services Market: Industry Trends and Global Forecasts, 2021-2030
    3. Clinical Trial Planning and Design Services Market: Industry Trends and Global Forecasts, 2021-2030
    4. Biospecimen Contract Research Services Market: Industry Trends and Global Forecast, 2021-2030
    5. Biologics Fill / Finish Services Market (2nd Edition): Industry Trends and Global Forecasts, 2021-2030

    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

    Contact Information
    Roots Analysis Private Limited
    Ben Johnson
    +1 (415) 800 3415
    +44 (122) 391 1091
    Ben.johnson@rootsanalysis.com
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis
    Medium - https://medium.com/@RootsAnalysis
    Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/
    Quora - https://rootsanalysisinsights.quora.com/
    The site management organizations (SMO) market The rapidly growing clinical pipeline and challenges associated with the conduct of clinical trials in a cost and time effective manner, has presented lucrative opportunities for service providers with expertise in clinical trial site management The Site Management Organizations Market report features an extensive study of the current market landscape and future potential of the site management organizations market. Roots Analysis has announced the addition of “Site Management Organizations (SMO) Market, 2021 – 2035” report to its list of offerings In recent years, drug / device developers have demonstrated a preference to continue relying on SMOs for conducting clinical trials in order to significantly optimize trial cost and research timelines. Driven by the steady growth in clinical research activity and inherent benefits offered by SMOs, the market opportunity for such players is projected to grow at a significant pace in the foreseen future. To order this 270+ page report, which features 95+ figures and 120+ tables, please visit https://www.rootsanalysis.com/reports/site-management-organizations-market.html Key Market Insights Around 250 companies across the world claim to offer clinical trial site management services Majority (43%) of the industry stakeholders are headquartered in North America, followed by those based in Asia-Pacific (32%) and Europe (19%). In addition, 25% of the companies engaged in this domain offer site management services across the globe, followed by those providing services in Asia-Pacific (23%). 200+ partnerships were established in this domain, during the period 2016-2021 Service alliances (26%) and clinical trial agreements (23%) emerged as the most common types of partnership models adopted by stakeholders engaged in this domain. Nearly 65% of the deals in this domain were established after 2018, with the maximum activity being reported in 2021 (56). ~USD 1 billion invested in various domain focused initiatives, since 2015 Maximum number of funding instances (21%) were reported in 2021, amounting to USD 614 million in capital investments. A significant number of funding instances (43%) were venture capital rounds, followed by instances of other equity (29%) and grants (7%). Till 2035, annual demand for clinical trial study participants is expected grow at a CAGR of 8.2% Currently, North America and Asia-Pacific hold the majority share of the overall demand for clinical trial study participants (60%). By 2035, the demand for patients in clinical trial studies is projected to reach 25 million. Further, currently, the highest demand is generated via phase III trials (43%), followed by phase IV studies (38%). North America and Europe are anticipated to capture close to 65% of the market share, by 2035 In addition, the market in Asia-Pacific is likely to grow at a relatively faster pace (9%) in the long term. Further, in 2035, the majority share (~45%) of clinical trial site management revenues is likely to be generated from trials focused on phase III evaluation of clinical studies. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/site-management-organizations-market.html Key Questions Answered  Who are the leading players engaged in the clinical trial site management domain?  What is the relative competitiveness of different site management organizations?  What type of partnership models are commonly adopted by stakeholders in this industry?  What is the capital investments trend in the site management organizations domain?  Which are the most active clinical trial centers?  What are the major market trends and driving factors that are likely to impact the growth of site management organizations market?  How is the current and future market opportunity likely to be distributed across key market segments? The financial opportunity within the SMOs market has been analyzed across the following segments:  Therapeutic Areas  Oncological Disorders  CNS Disorders  Infectious Diseases  Respiratory Disorders  Cardiovascular Diseases  Endocrine Disorders  Gastrointestinal Disorders  Musculoskeletal Diseases  Immunological Disorders  Others  Trial Phases  Phase I  Phase II  Phase III  Phase IV  Clinical Trial Components  Site Management  Onsite Monitoring  Project Management  Data Management  Regulatory Affairs  Logistics  Quality Control  Others  Types of Interventions  Therapeutics  Devices  Surgical Procedure  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  MENA  Rest of the World The report also features inputs from eminent industry stakeholders, according to whom, complexities associated with clinical trial processes and increasing clinical pipeline will drive the growth of the third-party service providers, such as SMOs, engaged in this domain, in the coming future. The report includes detailed transcripts of discussions held with the following experts:  Vinod Gyanchandani (Country Head - Clinical Operations, GDD Experts)  Marisa Vico (Medical Director and Operations Manager, SMO – Dra. Marisa Vico)  Eugene Winifred (Project Manager, Syncretic Clinical Research Services) The research includes profiles of key players (listed below); each profile features a brief overview of the company, details related to its site management service portfolio, recent developments and an informed future outlook.  FOMAT Medical Research  Parexel  Pharm-Olam  Veristat  WCCT Global  Worldwide Clinical Trials  CROMSOURCE  Fidelis Research  Scandinavian CRO  TFS HealthScience  Trialbee  CMIC  George Clinical  Tigermed  Veeda Clinical Research For additional details, please visit https://www.rootsanalysis.com/reports/site-management-organizations-market.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Patient Recruitment and Retention Services Market (2nd Edition): Industry Trends and Global Forecasts, 2021-2030 2. Pharmaceutical Contract Research Services Market: Industry Trends and Global Forecasts, 2021-2030 3. Clinical Trial Planning and Design Services Market: Industry Trends and Global Forecasts, 2021-2030 4. Biospecimen Contract Research Services Market: Industry Trends and Global Forecast, 2021-2030 5. Biologics Fill / Finish Services Market (2nd Edition): Industry Trends and Global Forecasts, 2021-2030 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact Information Roots Analysis Private Limited Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/
    Site Management Organizations Market | Market Size | Industry Analysis | 2035
    Site Management Organizations Market report features an extensive study of the current market landscape and future potential of the...
    WWW.ROOTSANALYSIS.COM
    0 Comments 0 Shares
  • The contract fill / finish services market for biologics is anticipated to be worth USD 4.2 billion by 2030, predicts Roots Analysis
    A steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers; stakeholders have invested heavily to ensure product integrity and safety

    Roots Analysis is pleased to announce the publication of its recent study, titled, “Biologics Fill / Finish Services Market, 2019-2030.”

    The report features an extensive study on the contract service providers offering drug product manufacturing services within the biopharmaceutical industry.

    To request a sample copy / brochure of this report, please visit
    https://www.rootsanalysis.com/reports/256/request-sample.html

    The study features in-depth analysis, highlighting the capabilities of a diverse set of companies that claim to specialize in fill / finish operations. Amongst other elements, the report includes:
     A detailed review of the overall landscape of contract fill / finish services market for biopharmaceuticals.
     A region-wise, company competitiveness analysis, highlighting prominent fill / finish service providers across various packaging types.
     Elaborate profiles of key players across key geographies (North America, Europe and Asia-Pacific).
     An analysis of the recent collaborations (signed since 2013) focused on the contract fill / finish services for biologics.
     A detailed analysis of the expansions undertaken (since 2013) by various service providers for augmenting their respective fill / finish service portfolios.
     An estimate of the global contract fill / finish capacity, by taking into consideration the capacities of various fill / finish service providers.
     An informed estimate of the annual demand for fill / finish of biologics, taking into account the top 20 biologics.
     An analysis to identify the key performance indicators for service providers active in the domain.
     A case study to highlight the benefits of using robotic / automated equipment for aseptic fill / finish processes.
     A case study to highlight the role of ready-to-use packaging containers in aseptic fill / finish operations.
     A discussion on the potential growth areas and recent trends impacting the outsourcing potential for biopharmaceuticals.
     A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
     Types of Primary Packaging Containers
     Ampoules
     Cartridges
     Syringes
     Vials
     Types of Biologics
     Peptides / proteins
     Antibodies
     Vaccines
     Cell therapies
     Gene therapies
     Viral products
     Oligonucleotides
     Others

     Company Size
     Small-sized
     Mid-sized
     Large / very large

     Scale of Operation
     Preclinical
     Clinical
     Commercial

     Key Therapeutic Areas
     Cancer
     Infectious diseases
     Autoimmune diseases
     Cardiovascular diseases
     Other indications

     Key Geographical Regions
     North America (US, Canada)
     Europe (UK, France, Germany, Italy, Spain and rest of the Europe)
     Asia-Pacific (Japan, China, South Korea, India and Australia)

    The report features inputs from a number of eminent industry stakeholders, according to whom, “Currently, majority of biologics are being filled in vials, however, the scenario is likely to change in the future due to the growing demand and preference for self-administration devices.” The report features detailed transcripts of discussions held with the following experts:
     Ales Sima, Business Development Manager, oncomed manufacturing
     Gregor Kawaletz, Chief Commercial Officer, IDT Biologika
     Jos Vergeest, International Business Developer, HALIX
     Purushottam Singnurkar, Research Director and Head of Formulation Development, Syngene International

    Key companies covered in the report
     Advanced BioScience Laboratories (ABL)
     Albany Molecular Research (AMRI)
     Biocon
     BioPharma Solutions
     BioReliance
     Boehringer Ingelheim BioXcellence
     ChemPartner
     Emergent BioSolutions
     IDT Biologika
     Lonza
     LuinaBio
     Mycenax Biotech
     Patheon
     Recipharm
     Vetter Pharma
     WuXi Biologics

    For more information please click on the following link:
    https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html

    Other Recent Offerings
    1. Vaccine Contract Manufacturing Market (2nd Edition), 2019-2030
    2. Medical Device Contract Manufacturing Market, 2019-2030
    3. Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures
    4. Biopharma Contract Manufacturing Market (3rd Edition), 2019 - 2030
    5. Patient Recruitment and Retention Services Market, 2019-2030

    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

    Contact Information
    Roots Analysis Private Limited
    Ben Johnson
    +1 (415) 800 3415
    ben.johnson@rootsanalysis.com
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis
    Medium - https://medium.com/@RootsAnalysis
    Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/
    Quora - https://rootsanalysisinsights.quora.com/
    The contract fill / finish services market for biologics is anticipated to be worth USD 4.2 billion by 2030, predicts Roots Analysis A steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers; stakeholders have invested heavily to ensure product integrity and safety Roots Analysis is pleased to announce the publication of its recent study, titled, “Biologics Fill / Finish Services Market, 2019-2030.” The report features an extensive study on the contract service providers offering drug product manufacturing services within the biopharmaceutical industry. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/256/request-sample.html The study features in-depth analysis, highlighting the capabilities of a diverse set of companies that claim to specialize in fill / finish operations. Amongst other elements, the report includes:  A detailed review of the overall landscape of contract fill / finish services market for biopharmaceuticals.  A region-wise, company competitiveness analysis, highlighting prominent fill / finish service providers across various packaging types.  Elaborate profiles of key players across key geographies (North America, Europe and Asia-Pacific).  An analysis of the recent collaborations (signed since 2013) focused on the contract fill / finish services for biologics.  A detailed analysis of the expansions undertaken (since 2013) by various service providers for augmenting their respective fill / finish service portfolios.  An estimate of the global contract fill / finish capacity, by taking into consideration the capacities of various fill / finish service providers.  An informed estimate of the annual demand for fill / finish of biologics, taking into account the top 20 biologics.  An analysis to identify the key performance indicators for service providers active in the domain.  A case study to highlight the benefits of using robotic / automated equipment for aseptic fill / finish processes.  A case study to highlight the role of ready-to-use packaging containers in aseptic fill / finish operations.  A discussion on the potential growth areas and recent trends impacting the outsourcing potential for biopharmaceuticals.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Types of Primary Packaging Containers  Ampoules  Cartridges  Syringes  Vials  Types of Biologics  Peptides / proteins  Antibodies  Vaccines  Cell therapies  Gene therapies  Viral products  Oligonucleotides  Others  Company Size  Small-sized  Mid-sized  Large / very large  Scale of Operation  Preclinical  Clinical  Commercial  Key Therapeutic Areas  Cancer  Infectious diseases  Autoimmune diseases  Cardiovascular diseases  Other indications  Key Geographical Regions  North America (US, Canada)  Europe (UK, France, Germany, Italy, Spain and rest of the Europe)  Asia-Pacific (Japan, China, South Korea, India and Australia) The report features inputs from a number of eminent industry stakeholders, according to whom, “Currently, majority of biologics are being filled in vials, however, the scenario is likely to change in the future due to the growing demand and preference for self-administration devices.” The report features detailed transcripts of discussions held with the following experts:  Ales Sima, Business Development Manager, oncomed manufacturing  Gregor Kawaletz, Chief Commercial Officer, IDT Biologika  Jos Vergeest, International Business Developer, HALIX  Purushottam Singnurkar, Research Director and Head of Formulation Development, Syngene International Key companies covered in the report  Advanced BioScience Laboratories (ABL)  Albany Molecular Research (AMRI)  Biocon  BioPharma Solutions  BioReliance  Boehringer Ingelheim BioXcellence  ChemPartner  Emergent BioSolutions  IDT Biologika  Lonza  LuinaBio  Mycenax Biotech  Patheon  Recipharm  Vetter Pharma  WuXi Biologics For more information please click on the following link: https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html Other Recent Offerings 1. Vaccine Contract Manufacturing Market (2nd Edition), 2019-2030 2. Medical Device Contract Manufacturing Market, 2019-2030 3. Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures 4. Biopharma Contract Manufacturing Market (3rd Edition), 2019 - 2030 5. Patient Recruitment and Retention Services Market, 2019-2030 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact Information Roots Analysis Private Limited Ben Johnson +1 (415) 800 3415 ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/
    Request Sample - Biologics Fill Finish Service Providers Market (2nd Edition) | Industry Analysis | Market Size | 2030
    With a current capacity of 3.5 million liters, the biologics fill/finish services market is equiped to handle future demand, growing at a healthy CAGR of ~10%
    WWW.ROOTSANALYSIS.COM
    0 Comments 0 Shares
  • The contract fill / finish services market for - Roots Analysis
    A steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers; stakeholders have invested heavily to ensure product integrity and safety

    Roots Analysis is pleased to announce the publication of its recent study, titled, “Biologics Fill / Finish Services Market, 2019-2030.”

    The report features an extensive study on the contract service providers offering drug product manufacturing services within the biopharmaceutical industry. The study features in-depth analysis, highlighting the capabilities of a diverse set of companies that claim to specialize in fill / finish operations. Amongst other elements, the report includes:
     A detailed review of the overall landscape of contract fill / finish services market for biopharmaceuticals.
     A region-wise, company competitiveness analysis, highlighting prominent fill / finish service providers across various packaging types.
     Elaborate profiles of key players across key geographies (North America, Europe and Asia-Pacific).
     An analysis of the recent collaborations (signed since 2013) focused on the contract fill / finish services for biologics.
     A detailed analysis of the expansions undertaken (since 2013) by various service providers for augmenting their respective fill / finish service portfolios.
     An estimate of the global contract fill / finish capacity, by taking into consideration the capacities of various fill / finish service providers.
     An informed estimate of the annual demand for fill / finish of biologics, taking into account the top 20 biologics.
     An analysis to identify the key performance indicators for service providers active in the domain.
     A case study to highlight the benefits of using robotic / automated equipment for aseptic fill / finish processes.
     A case study to highlight the role of ready-to-use packaging containers in aseptic fill / finish operations.
     A discussion on the potential growth areas and recent trends impacting the outsourcing potential for biopharmaceuticals.
     A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
     Types of Primary Packaging Containers
     Ampoules
     Cartridges
     Syringes
     Vials
     Types of Biologics
     Peptides / proteins
     Antibodies
     Vaccines
     Cell therapies
     Gene therapies
     Viral products
     Oligonucleotides
     Others

     Company Size
     Small-sized
     Mid-sized
     Large / very large

     Scale of Operation
     Preclinical
     Clinical
     Commercial

     Key Therapeutic Areas
     Cancer
     Infectious diseases
     Autoimmune diseases
     Cardiovascular diseases
     Other indications

     Key Geographical Regions
     North America (US, Canada)
     Europe (UK, France, Germany, Italy, Spain and rest of the Europe)
     Asia-Pacific (Japan, China, South Korea, India and Australia)

    The report features inputs from a number of eminent industry stakeholders, according to whom, “Currently, majority of biologics are being filled in vials, however, the scenario is likely to change in the future due to the growing demand and preference for self-administration devices.” The report features detailed transcripts of discussions held with the following experts:
     Ales Sima, Business Development Manager, oncomed manufacturing
     Gregor Kawaletz, Chief Commercial Officer, IDT Biologika
     Jos Vergeest, International Business Developer, HALIX
     Purushottam Singnurkar, Research Director and Head of Formulation Development, Syngene International

    Key companies covered in the report
     Advanced BioScience Laboratories (ABL)
     Albany Molecular Research (AMRI)
     Biocon
     BioPharma Solutions
     BioReliance
     Boehringer Ingelheim BioXcellence
     ChemPartner
     Emergent BioSolutions
     IDT Biologika
     Lonza
     LuinaBio
     Mycenax Biotech
     Patheon
     Recipharm
     Vetter Pharma
     WuXi Biologics

    For more information please click on the following link:
    https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html

    Other Recent Offerings
    1. Vaccine Contract Manufacturing Market (2nd Edition), 2019-2030
    2. Medical Device Contract Manufacturing Market, 2019-2030
    3. Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures
    4. Biopharma Contract Manufacturing Market (3rd Edition), 2019 - 2030
    5. Patient Recruitment and Retention Services Market, 2019-2030


    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

    Contact Information
    Roots Analysis Private Limited
    Ben Johnson
    +1 (415) 800 3415
    ben.johnson@rootsanalysis.com
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis
    Medium: https://medium.com/@RootsAnalysis
    Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/
    Quora: https://rootsanalysisinsights.quora.com/
    The contract fill / finish services market for - Roots Analysis A steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers; stakeholders have invested heavily to ensure product integrity and safety Roots Analysis is pleased to announce the publication of its recent study, titled, “Biologics Fill / Finish Services Market, 2019-2030.” The report features an extensive study on the contract service providers offering drug product manufacturing services within the biopharmaceutical industry. The study features in-depth analysis, highlighting the capabilities of a diverse set of companies that claim to specialize in fill / finish operations. Amongst other elements, the report includes:  A detailed review of the overall landscape of contract fill / finish services market for biopharmaceuticals.  A region-wise, company competitiveness analysis, highlighting prominent fill / finish service providers across various packaging types.  Elaborate profiles of key players across key geographies (North America, Europe and Asia-Pacific).  An analysis of the recent collaborations (signed since 2013) focused on the contract fill / finish services for biologics.  A detailed analysis of the expansions undertaken (since 2013) by various service providers for augmenting their respective fill / finish service portfolios.  An estimate of the global contract fill / finish capacity, by taking into consideration the capacities of various fill / finish service providers.  An informed estimate of the annual demand for fill / finish of biologics, taking into account the top 20 biologics.  An analysis to identify the key performance indicators for service providers active in the domain.  A case study to highlight the benefits of using robotic / automated equipment for aseptic fill / finish processes.  A case study to highlight the role of ready-to-use packaging containers in aseptic fill / finish operations.  A discussion on the potential growth areas and recent trends impacting the outsourcing potential for biopharmaceuticals.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Types of Primary Packaging Containers  Ampoules  Cartridges  Syringes  Vials  Types of Biologics  Peptides / proteins  Antibodies  Vaccines  Cell therapies  Gene therapies  Viral products  Oligonucleotides  Others  Company Size  Small-sized  Mid-sized  Large / very large  Scale of Operation  Preclinical  Clinical  Commercial  Key Therapeutic Areas  Cancer  Infectious diseases  Autoimmune diseases  Cardiovascular diseases  Other indications  Key Geographical Regions  North America (US, Canada)  Europe (UK, France, Germany, Italy, Spain and rest of the Europe)  Asia-Pacific (Japan, China, South Korea, India and Australia) The report features inputs from a number of eminent industry stakeholders, according to whom, “Currently, majority of biologics are being filled in vials, however, the scenario is likely to change in the future due to the growing demand and preference for self-administration devices.” The report features detailed transcripts of discussions held with the following experts:  Ales Sima, Business Development Manager, oncomed manufacturing  Gregor Kawaletz, Chief Commercial Officer, IDT Biologika  Jos Vergeest, International Business Developer, HALIX  Purushottam Singnurkar, Research Director and Head of Formulation Development, Syngene International Key companies covered in the report  Advanced BioScience Laboratories (ABL)  Albany Molecular Research (AMRI)  Biocon  BioPharma Solutions  BioReliance  Boehringer Ingelheim BioXcellence  ChemPartner  Emergent BioSolutions  IDT Biologika  Lonza  LuinaBio  Mycenax Biotech  Patheon  Recipharm  Vetter Pharma  WuXi Biologics For more information please click on the following link: https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html Other Recent Offerings 1. Vaccine Contract Manufacturing Market (2nd Edition), 2019-2030 2. Medical Device Contract Manufacturing Market, 2019-2030 3. Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures 4. Biopharma Contract Manufacturing Market (3rd Edition), 2019 - 2030 5. Patient Recruitment and Retention Services Market, 2019-2030 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact Information Roots Analysis Private Limited Ben Johnson +1 (415) 800 3415 ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium: https://medium.com/@RootsAnalysis Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/ Quora: https://rootsanalysisinsights.quora.com/
    0 Comments 0 Shares
  • Factors That Impact Clinical Trial Patient Recruitment
    https://vialtrial.tumblr.com/post/655380883304513536/factors-that-impact-clinical-trial-patient

    If you're looking for job opportunities in clinical research or want to become a member of the trial, a vial trial is here. To know factors that impact clinical trial patient recruitment, read this blog here!
    Factors That Impact Clinical Trial Patient Recruitment https://vialtrial.tumblr.com/post/655380883304513536/factors-that-impact-clinical-trial-patient If you're looking for job opportunities in clinical research or want to become a member of the trial, a vial trial is here. To know factors that impact clinical trial patient recruitment, read this blog here!
    0 Comments 0 Shares
  • FOMAT Medical Research offers solutions for Sponsors, CRO’s and sites. We have over 15 years of experience participating in clinical research in a wide variety of therapeutic areas. Our qualified research network offers services in site management, patient recruitment, regulatory affairs, and more. For more information, visit our website at - https://www.fomatmedical.com/2018/11/top-cros/
    FOMAT Medical Research offers solutions for Sponsors, CRO’s and sites. We have over 15 years of experience participating in clinical research in a wide variety of therapeutic areas. Our qualified research network offers services in site management, patient recruitment, regulatory affairs, and more. For more information, visit our website at - https://www.fomatmedical.com/2018/11/top-cros/
    0 Comments 0 Shares

No results to show

No results to show

No results to show

No results to show

Sponsored